Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X L Ren

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Cancer Research and Clinical Oncology|October 31, 2015
MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2X L Ren, G Y He, X M Li, et al.
Journal of Cancer Research and Clinical Oncology|September 21, 2014
Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancerX L Ren, X H Zhu, X M Li, et al.
Cancer Letters|January 29, 2018
Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formationX L Ren, Y D Qiao, J Y Li, et al.
British Journal of Cancer|August 18, 2017
FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancerS S Yang, X M Li, M Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized studyY K Shi, L Wang, B H Han, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Cancer Research and Clinical Oncology|October 31, 2015
MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2X L Ren, G Y He, X M Li, et al.
Journal of Cancer Research and Clinical Oncology|September 21, 2014
Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancerX L Ren, X H Zhu, X M Li, et al.
Cancer Letters|January 29, 2018
Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formationX L Ren, Y D Qiao, J Y Li, et al.
British Journal of Cancer|August 18, 2017
FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancerS S Yang, X M Li, M Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized studyY K Shi, L Wang, B H Han, et al.
Pageof 4